Breaking News Instant updates and real-time market news.

NVCN

Neovasc

$1.12

-0.04 (-3.45%)

16:08
08/10/17
08/10
16:08
08/10/17
16:08

Neovasc reports on going concern prospects

Neovasc may be faced with significant monetary damages in the litigation with CardiAQ that could exceed its resources and/or the loss of intellectual property rights that could have a material adverse effect on the company and its financial condition. These circumstances indicate the existence of material uncertainty and cast substantial doubt about the company's ability to continue as a going concern.

  • 26

    Sep

NVCN Neovasc
$1.12

-0.04 (-3.45%)

04/05/17
LTCO
04/05/17
UPGRADE
Target $4
LTCO
Buy
Neovasc upgraded to Buy on Reducer and Tiara advancement at Ladenburg
As previously reported, Ladenburg analyst Jeffrey Cohen upgraded Neovasc to Buy from Neutral with a $4 price target. The analyst told investors he is encouraged by Reducer update combined with Tiara's pace of clinical work. He expects current litigation will conclude in 2H 2017 and that the current scenario of decision/liabilities represents a worse case scenario with potential upside from a reversal of decisions and/or liabilities.
04/05/17
LTCO
04/05/17
UPGRADE
LTCO
Buy
Neovasc upgraded to Buy from Neutral at Ladenburg
12/02/16
LEER
12/02/16
NO CHANGE
LEER
Outperform
Neovasc's Boston Scientific deal provides a reprieve, says Leerink
Leerink analyst Danielle Antalffy said Neovasc (NVCN) share are reacting positively to the announcement that Boston Scientific (BSX) is aquiring tissue manufacturing assets and a 15% stake on the company for $75M. The analyst said the deal significantly improves its ability to continue to operate regardless of the outcome of ongoing litigation and believes the likelihood that Neovasc can continue to operate has increased substantially. Antalffy rates Neovasc an Outperform.

TODAY'S FREE FLY STORIES

DDS

Dillard's

$55.18

-0.75 (-1.34%)

15:10
08/17/17
08/17
15:10
08/17/17
15:10
Options
Dillards draws defensive option flow as shares fall »

Dillards draws defensive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:05
08/17/17
08/17
15:05
08/17/17
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

EPD

Enterprise Products

$25.07

-0.1 (-0.40%)

15:00
08/17/17
08/17
15:00
08/17/17
15:00
Options
Put buyers in Energy Products Partners »

Put buyers in Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$36.84

-2.11 (-5.42%)

14:58
08/17/17
08/17
14:58
08/17/17
14:58
Recommendations
L Brands analyst commentary  »

L Brands not in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

NUE

Nucor

$54.75

-1.98 (-3.49%)

14:58
08/17/17
08/17
14:58
08/17/17
14:58
Syndicate
Breaking Syndicate news story on Nucor »

Nucor files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$29.21

0.03 (0.10%)

, TSRO

Tesaro

$112.99

-1.01 (-0.89%)

14:50
08/17/17
08/17
14:50
08/17/17
14:50
Recommendations
AstraZeneca, Tesaro, Clovis analyst commentary  »

Lynparza labeling could…

AZN

AstraZeneca

$29.21

0.03 (0.10%)

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

CLVS

Clovis

$71.77

-0.11 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

GOOG

Alphabet

$926.96

4.74 (0.51%)

, GOOGL

Alphabet Class A

$944.27

6.19 (0.66%)

14:50
08/17/17
08/17
14:50
08/17/17
14:50
Periodicals
Google piloting data-friendly Search app in Indonesia, TechCrunch reports »

Google is pilot testing a…

GOOG

Alphabet

$926.96

4.74 (0.51%)

GOOGL

Alphabet Class A

$944.27

6.19 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

AMAT

Applied Materials

$44.46

0.58 (1.32%)

14:49
08/17/17
08/17
14:49
08/17/17
14:49
Options
Applied Materials options imply 6.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

AZN

AstraZeneca

$29.17

-0.015 (-0.05%)

, CLVS

Clovis

$71.77

-0.11 (-0.15%)

14:44
08/17/17
08/17
14:44
08/17/17
14:44
Hot Stocks
Feuerstein says Lynparza approval shows FDA sees no differences in PARPs »

STAT's Adam…

AZN

AstraZeneca

$29.17

-0.015 (-0.05%)

CLVS

Clovis

$71.77

-0.11 (-0.15%)

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

FSM

Fortuna Silver Mines

$4.49

-0.01 (-0.22%)

14:30
08/17/17
08/17
14:30
08/17/17
14:30
Options
6.5K Fortuna Silver Mines Aug - Sep 4 call spreads for 9c »

6.5K Fortuna Silver Mines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:30
08/17/17
08/17
14:30
08/17/17
14:30
General news
NY Fed's Survey of Primary Dealers showed expectations for December hike »

NY Fed's Survey of…

PCLN

Priceline

$1,855.72

-5.115 (-0.27%)

14:26
08/17/17
08/17
14:26
08/17/17
14:26
Recommendations
Priceline analyst commentary  »

Priceline recent pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAH

Platform Specialty Products

$12.21

-0.345 (-2.75%)

14:25
08/17/17
08/17
14:25
08/17/17
14:25
Options
Platform Specialty Products call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
08/17/17
08/17
14:25
08/17/17
14:25
General news
Canada CPI Preview »

Canada CPI Preview:…

TLSYY

Telstra

$17.11

0.585 (3.54%)

14:23
08/17/17
08/17
14:23
08/17/17
14:23
Downgrade
Telstra rating change  »

Telstra downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$57.49

-0.785 (-1.35%)

, XLI

Industrial Select Sector SPDR

$67.77

-0.84 (-1.22%)

14:23
08/17/17
08/17
14:23
08/17/17
14:23
Technical Analysis
Technical View: S&P 500 breaks another support layer »

The S&P 500 (SPX) is…

XLK

Technology Select Sector SPDR

$57.49

-0.785 (-1.35%)

XLI

Industrial Select Sector SPDR

$67.77

-0.84 (-1.22%)

XLY

Consumer Discretionary Sector SPDR

$89.23

-0.9 (-1.00%)

XLF

Financial Select Sector

$24.78

-0.26 (-1.04%)

SPY

SPDR S&P 500 ETF Trust

$244.48

-2.465 (-1.00%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$111.10

-0.48 (-0.43%)

14:18
08/17/17
08/17
14:18
08/17/17
14:18
Hot Stocks
ADP says Pershing presentation contains nothing not already analyzed »

ADP issued a statement in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

$NSD

NASDAQ Market Internals

14:17
08/17/17
08/17
14:17
08/17/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$30.29

-0.01 (-0.03%)

14:16
08/17/17
08/17
14:16
08/17/17
14:16
Hot Stocks
Goodyear Tire names Christopher Helsel Chief Technology Officer »

The Goodyear Tire &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
08/17/17
08/17
14:16
08/17/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USB

U.S. Bancorp

$52.02

-0.83 (-1.57%)

14:15
08/17/17
08/17
14:15
08/17/17
14:15
Options
US Bancorp put volume heavy and directionally bearish »

Bearish flow noted in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 18

    Oct

  • 17

    Jan

14:10
08/17/17
08/17
14:10
08/17/17
14:10
General news
Fed dove Kashkari said Fed would consider the debt ceiling »

Fed dove Kashkari said…

AVGO

Broadcom

$253.42

-0.27 (-0.11%)

, CSCO

Cisco

$32.34

0.25 (0.78%)

14:08
08/17/17
08/17
14:08
08/17/17
14:08
Hot Stocks
FTC approves final order on Broadcom's acquisition of Brocade »

Following a public…

AVGO

Broadcom

$253.42

-0.27 (-0.11%)

CSCO

Cisco

$32.34

0.25 (0.78%)

BRCD

Brocade

$12.24

0.03 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 24

    Aug

  • 06

    Sep

TXMD

TherapeuticsMD

$6.31

0.3718 (6.26%)

14:05
08/17/17
08/17
14:05
08/17/17
14:05
Options
TherapeuticsMD call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

14:02
08/17/17
08/17
14:02
08/17/17
14:02
General news
Trump condemns terror attack in Barcelona, says 'we love you' »

President Trump just…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.